144 related articles for article (PubMed ID: 35466461)
21. A case of metastatic extramammary Paget's disease that responded to combination chemotherapy.
Yamazaki N; Yamamoto A; Wada T; Ishikawa M; Moriya Y; Nakanishi Y
J Dermatol; 1999 May; 26(5):311-6. PubMed ID: 10380432
[TBL] [Abstract][Full Text] [Related]
22. Extramammary Paget's Disease.
Asel M; LeBoeuf NR
Hematol Oncol Clin North Am; 2019 Feb; 33(1):73-85. PubMed ID: 30497678
[TBL] [Abstract][Full Text] [Related]
23. Tumor thickness as a prognostic factor in extramammary Paget's disease.
Ito T; Kaku Y; Nagae K; Nakano-Nakamura M; Nakahara T; Oda Y; Hagihara A; Furue M; Uchi H
J Dermatol; 2015 Mar; 42(3):269-75. PubMed ID: 25557434
[TBL] [Abstract][Full Text] [Related]
24. Prognosis and management of extramammary Paget's disease and the association with secondary malignancies.
Pierie JP; Choudry U; Muzikansky A; Finkelstein DM; Ott MJ
J Am Coll Surg; 2003 Jan; 196(1):45-50. PubMed ID: 12517548
[TBL] [Abstract][Full Text] [Related]
25. Multidisciplinary Approach for the Management of Penoscrotal Extramammary Paget's disease -An eUROGEN study.
Christodoulidou M; Alnajjar HM; Parnham A; Khetrapal P; Freeman A; Haider A; Mitra AV; Bunker CB; Muneer A
Urol Oncol; 2021 Aug; 39(8):501.e1-501.e10. PubMed ID: 34193377
[TBL] [Abstract][Full Text] [Related]
26. Neutrophil-to-lymphocyte ratio is a potential prognostic biomarker for extramammary Paget disease: A retrospective study.
Maeda T; Uehara J; Toyoshima R; Nakagawa T; Yoshino K
J Dermatol; 2022 Nov; 49(11):1188-1192. PubMed ID: 35903974
[TBL] [Abstract][Full Text] [Related]
27. The diagnosis and management of extramammary Paget's disease.
Ito T; Kaku-Ito Y; Furue M
Expert Rev Anticancer Ther; 2018 Jun; 18(6):543-553. PubMed ID: 29575944
[TBL] [Abstract][Full Text] [Related]
28. Cyclin-dependent kinase 4/6 inhibitors suppress tumor growth in extramammary Paget's disease.
Kitamura S; Yanagi T; Maeda T; Ujiie H
Cancer Sci; 2022 Feb; 113(2):802-807. PubMed ID: 34866279
[TBL] [Abstract][Full Text] [Related]
29. Extramammary Paget's disease: an annotated review.
Balducci L; Crawford ED; Smith GF; Lambuth B; McGehee R; Hardy C
Cancer Invest; 1988; 6(3):293-303. PubMed ID: 2844363
[TBL] [Abstract][Full Text] [Related]
30. Efficacy and safety of HpD-PDT for Extramammary Paget's Disease refractory to conventional therapy: A prospective, open-label and single arm pilot study.
Wang D; Wang P; Li C; Zhou Z; Zhang L; Zhang G; Wang X
Photodiagnosis Photodyn Ther; 2022 Mar; 37():102670. PubMed ID: 34883272
[TBL] [Abstract][Full Text] [Related]
31. Extramammary Paget's Disease in Two Brothers.
Zhang X; Jin W; Zhu H; Yu H
Indian J Dermatol; 2015; 60(4):423. PubMed ID: 26288451
[TBL] [Abstract][Full Text] [Related]
32. Clinical and pathological characteristics of extramammary Paget's disease: report of 246 Chinese male patients.
Kang Z; Zhang Q; Zhang Q; Li X; Hu T; Xu X; Wu Z; Zhang X; Wang H; Xu J; Xu F; Guan M
Int J Clin Exp Pathol; 2015; 8(10):13233-40. PubMed ID: 26722523
[TBL] [Abstract][Full Text] [Related]
33. Initial topical monotherapy may increase the risk of recurrence in patients with extramammary Paget's disease.
Choi S; Oh Y; Roh MR; Chung KY; Oh BH
J Dermatol; 2021 May; 48(5):585-591. PubMed ID: 33666282
[TBL] [Abstract][Full Text] [Related]
34. Combination Cisplatin-Epirubicin-Paclitaxel Therapy for Metastatic Extramammary Paget's Disease.
Hirai I; Tanese K; Nakamura Y; Ishii M; Kawakami Y; Funakoshi T
Oncologist; 2019 Jun; 24(6):e394-e396. PubMed ID: 30846514
[TBL] [Abstract][Full Text] [Related]
35. Overexpression of Janus kinase 2 protein in extramammary Paget's disease.
Otsuka-Maeda S; Mijiddorj MT; Kajihara I; Sakamoto R; Yamada-Kanazawa S; Kanemaru H; Nishimura Y; Sawamura S; Makino K; Aoi J; Makino T; Masuguchi S; Fukushima S; Ihn H
Jpn J Clin Oncol; 2021 Jul; 51(7):1176-1178. PubMed ID: 33912910
[TBL] [Abstract][Full Text] [Related]
36. NECTIN4-targeted antibody-drug conjugate is a potential therapeutic option for extramammary Paget disease.
Tanaka Y; Ito T; Murata M; Tanegashima K; Kaku-Ito Y; Nakahara T
Exp Dermatol; 2024 Mar; 33(3):e15049. PubMed ID: 38509717
[TBL] [Abstract][Full Text] [Related]
37. KS-EMPD-1: a novel cell line of primary extramammary Paget's disease.
Ito T; Tanaka Y; Ichiki T; Kaku-Ito Y; Nakahara T
Hum Cell; 2023 Sep; 36(5):1813-1829. PubMed ID: 37432591
[TBL] [Abstract][Full Text] [Related]
38. Primary invasive carcinoma associated with penoscrotal extramammary Paget's disease: a clinicopathological analysis of 56 cases.
Dai B; Kong YY; Chang K; Qu YY; Ye DW; Zhang SL; Zhang HL
BJU Int; 2015 Jan; 115(1):153-60. PubMed ID: 24731175
[TBL] [Abstract][Full Text] [Related]
39. Combination chemotherapy for metastatic extramammary Paget disease.
Oashi K; Tsutsumida A; Namikawa K; Tanaka R; Omata W; Yamamoto Y; Yamazaki N
Br J Dermatol; 2014 Jun; 170(6):1354-7. PubMed ID: 24329551
[TBL] [Abstract][Full Text] [Related]
40. Prognostic indicators in 35 patients with extramammary Paget's disease.
Ito Y; Igawa S; Ohishi Y; Uehara J; Yamamoto AI; Iizuka H
Dermatol Surg; 2012 Dec; 38(12):1938-44. PubMed ID: 22989161
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
